Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05935800 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 19, 2024 to Apr 19, 2027
    • Study completion date: Apr 19, 2024 to Apr 19, 2028
    • Study description shortened, about 1 word
    v3
  2. Primary endpoints: 1 to 2
    • Secondary endpoints: 1 to 3
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decreased patient strength and vitality.
Trial Details
NCT Number NCT05935800
Lead Sponsor Methodist Health System
Conditions
(from sponsor)		 Frailty, Sarcopenia, COVID-19
Related terms COVID-19, Frailty, Sarcopenia
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov